Replies to post #4087818 on BB's Stock Haven

[whatarush12]

VDRM ~ DOCS from all over the world will hear about ViaDerma!

Starosolska, Joanna <[e-mail]>
9:39 AM Wednesday, March 15, 2017

to me
Good morning,
Dr. Otiko has been invited to present his poster during the poster session at DFCon. This is a formal session, but it is not an exclusive speaking event.
Poster session will take place on March 24 from 11:40 am to 2:20 pm.

With kind regards,
Joanna Starosolska
Administrative Secretary
Division of Vascular Surgery
Baylor College of Medicine
One Baylor Plaza, MS 390
Houston, TX 77030
Ph: 713-798-7851
Fx: 713-798-2744
DFCon 2017

cid:image004.jpg@01D12770.3F6AF690

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

dfcon.com/

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

February 8, 2017
~ CEO speaking at the Global Diabetic Foot Conference in Houston March 23-25, 2017 ~
http://www.marketwired.com/press-release/dr-chris-ayo-otiko-president-viaderma-inc-is-selected-write-article-healing-diabetic-otc-pink-vdrm-2194656.htm

https://www.drugs.com/otc/676986/viabecline.html
https://www.linkedin.com/pulse/healing-diabetic-ulcers-dave-pozek-1
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129403043
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129390203
message_id=129040891
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128962099


>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

February 3, 2017
~ MASSIVE sales coming.. 500,000 units x $125 = $62,500,000 in 2017~
http://www.marketwired.com/press-release/viaderma-inc-targets-online-sales-wound-care-centers-distribution-companies-its-viabecline-pinksheets-vdrm-2193323.htm

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129402236
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129339194
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129286070


January 11, 2017
~Filed a patent application with the USPTO for its proprietary innovative transdermal delivery system~
http://www.marketwired.com/press-release/viaderma-incs-ceo-files-new-patent-application-signs-two-licensing-deals-locates-product-otc-pink-vdrm-2187878.htm

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129386093
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129283860


November 30, 2016
"Patent Pending Transdermal System" can deliver medications and nutrients into the body through the skin. The solution combined with FDA registered drugs can increase the absorption as much as 100 times directly to the localized treatment areas,
http://www.marketwired.com/press-release/viaderma-inc-clinical-studies-abroad-europe-middle-east-asia-show-promising-results-otc-pink-vdrm-2179850.htm


November 14, 2016
Filed Patent Pending use of its innovative transdermal system for the delivery of (CBD's) Calanoids and (THC) Tetrahydrocannabinol for the treatment of several diseases
http://www.marketwired.com/press-release/viaderma-inc-enters-mmj-medical-marijuana-industry-with-patent-pending-cbd-delivery-otc-pink-vdrm-2175498.htm

[Rainer]

PMEA basing at .0007 support